Literature DB >> 18232321

[Magnetic resonance angiographic occlusion of the cervical carotid artery at 3 tesla: its pitfalls].

Yui Mano1, Hiroaki Shimizu, Takashi Inoue, Teiji Tominaga.   

Abstract

Magnetic resonance angiography (MRA) is one of the most popular tools for imaging cerebral arteries. However, it may overestimate steno-occlusive lesions. The purpose of the present study was to investigate the diagnostic accuracy of cervical MRA for carotid steno-occlusive lesions. This study included 13 sides of 12 patients (male: female = 11: 1, 53-83 years old) who showed cervical carotid occlusion on MRA at 3 tesla. The MRA was performed along with time-resolved imaging of contrast kinetics (TRICKS) and/or black blood imaging (BBI) when detailed evaluation was considered necessary after routine 1.5 tesla MRA. All patients underwent digital subtraction angiography (DSA) for definitive diagnosis. Cervical duplex scan was also performed in 12 sides. DSA demonstrated occlusion in only 6 sides (46.2%). In the remaining 7 sides, in spite of occlusion on MRA, DSA demonstrated stenoses in 4 sides and pseudoocclusions in 3 sides. Adding TRICKS or BBI resulted in correct diagnosis (same as DSA) in 6 sides. In comparison to DSA, sensitivity and specificity of combination of TRICKS and BBI were 100% and 85.7%, respectively, for the diagnosis of cervical carotid occlusion. In conclusion, MRA alone does not accurately demonstrate severe stenosis of the cervical carotid artery and may miss surgical candidates. TRICKS and BBI are useful adjunct tools for an accurate diagnosis.

Entities:  

Mesh:

Year:  2008        PMID: 18232321

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  1 in total

Review 1.  Vascular wall imaging of vulnerable atherosclerotic carotid plaques: current state of the art and potential future of endovascular optical coherence tomography.

Authors:  B A Standish; J Spears; T R Marotta; W Montanera; V X D Yang
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.